Company / Operating Cash Flow
CHINA PHARMA HOLDINGS, INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$148.3K
FY2025
5-year range
-$699.7K / $148.3K
FY2021-FY2025
Trend
+121.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$699,686 to $148,261 over the past 2 years.
Based on SEC 10-K filings.
$148,261 in FY2025 with a 5-year CAGR of -24.6%.
Improved from -$699,686 to $148,261 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -24.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -24.6%, indicating a declining trend.
- In FY2025, operating cash flow increased 121.2% year-over-year.
- Peak operating cash flow was recorded in FY2016.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $148.3K | +121.2% |
| FY2024 | -$699.7K | +0.0% |
| FY2023 | -$699.7K | -70.8% |
| FY2022 | -$409.5K | -869.1% |
| FY2021 | -$42.3K | -106.9% |
| FY2020 | $608.3K | -67.7% |
| FY2019 | $1.9M | +123.7% |
| FY2018 | $841.2K | -70.9% |
| FY2017 | $2.9M | -13.6% |
| FY2016 | $3.4M | -45.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026